Vasomotor Symptoms

VANCOUVER, British Columbia — September 16, 2026 AbCellera announced that it will present Phase 2 efficacy and safety data...

VANCOUVER, British Columbia, August 10, 2026 AbCellera Biologics Inc. announced positive topline results from the Phase 2 portion of...

VANCOUVER, British Columbia, August 7, 2026 AbCellera announced that it will release top-line results from the Phase 2 clinical...

TOKYO, August 7, 2026 Astellas Pharma announced the submission of a New Drug Application (NDA) to Japan’s Ministry of...

BASEL, Switzerland and BOSTON, MA, May 1, 2026 Noema Pharma AG announced the presentation of positive Phase 2a clinical...